Cite

    Panagiotis Efentakis et al.. “Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.” Cardiovascular research, vol. 116, no. 3, 2020, pp. 576–591. http://access.bl.uk/ark:/81055/vdc_100101912593.0x000063